Clinical Trials Browser

Terminated × Midazolam × Tumor-Agnostic × Clear all

NCT02244112 2021-02-21

A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies

Phase 1 Terminated

Neoplasms